Wednesday, June 20, 2018 9:14:50 AM
January quarterly, page 14 (2nd paragraph included only to show the insertion of new (backdated?) transaction:
On November 10, 2017, William White sold his controlling interest of 116,747,700 Series A Preferred shares to Utopya Innovations, Inc. Following this sale, on November 28, 2017, William White resigned from all positions with the Company and Michael Starkweather was appointed as its sole officer and Director.
As of January 31, 2018, there were 3,579,209,650 Common shares issued at .00001 par, 130,000,000 Series A Preferred shares issued at .00001 par, 18,752,860 Series B Preferred shares issued at .00001 par, 634,254 Series C Preferred shares at .00001 par, and 25,000 Series E Preferred shares at .00001 par.
Note: There were 0 series D issued and outstanding in that quarterly.
Now in this newest quarterly:
On November 10, 2017, William White sold his controlling interest of 116,747,700 Series A Preferred shares to Utopya Innovations, Inc. Following this sale, on November 28, 2017, William White resigned from all positions with the Company and Michael Starkweather was appointed as its sole officer and Director.
On November 28, 2017, Utopya Innovations, Inc. sold its controlling interest of 116,747,700 Series A Preferred shares to Ian Brewster. Following this sale, on November 28, 2017, Utopya Innovations, Inc. was acquired by the Company in an all stock transaction where Utopya Innovations became wholly-owned and received the series D preferred stock.
As of January 31, 2018, there were 3,579,209,650 Common shares issued at .00001 par, 130,000,000 Series A Preferred shares issued at .00001 par, 18,752,860 Series B Preferred shares issued at .00001 par, 634,254 Series C Preferred shares at .00001 par, 2,000,000 Series D Preferred shares at .00001 par, and 25,000 Series E Preferred shares at .00001 par.
Note the newly inserted transaction.
Appears to have been prepared by rank amateurs.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM